Ultragenyx’s Crysvita scores FDA nod in 2nd ultra-rare bone disorder kblankenship Thu, 06/18/2020 – 14:03 More: Ultragenyx's Crysvita scores FDA nod in 2nd ultra-rare bone disorder Source: fierce
read moreRoche redeems itself with new Tecentriq win in early triple-negative breast cancer aliu Thu, 06/18/2020 – 10:17 More: Roche redeems itself with new Tecentriq win in early triple-negative breast cancer Source: fierce
read moreJudge wipes out Biogen’s Tecfidera patent protections in suit against Mylan esagonowsky Thu, 06/18/2020 – 09:33 More: Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan Source: fierce
read moreLegacy nabs Missouri plant to amp up logistics and packaging work fkansteiner Thu, 06/18/2020 – 09:23 More: Legacy nabs Missouri plant to amp up logistics and packaging work Source: fierce
read moreRoche’s Actemra falls short in Italian study in early-stage COVID-19 pneumonia esagonowsky Thu, 06/18/2020 – 09:12 More: Roche's Actemra falls short in Italian study in early-stage COVID-19 pneumonia Source: fierce
read moreLess patients who received the Tecentriq combination before surgery had evidence of tumour tissue detectable at the time of surgery More: Roche's Tecentriq shows promise in early triple-negative breast cancer Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals